Fistülizan Tip Crohn Hastalığında İnfliksimab Kullanımı Sonrasında Yaygın Tüberküloz Enfeksiyonu Gelişen Bir Olgu – Reaktivasyon mu? IRIS mı?

Cilt: 32 Sayı: 2 1 Haziran 2006
  • Murat Kıyıcı
  • Güze Özal
  • Enver Dolar
  • Macit Gülten
  • Selim Giray Nak
  • Selim Gürel
  • Hüseyin Uslusoy
  • Murat Keskin
Uludağ Üniversitesi Tıp Fakültesi Dergisi Kapak
Uludağ Üniversitesi Tıp Fakültesi Dergisi
PDF İndir
EN TR

A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn's Disease – Is It a Reactivation or IRIS?

Öz

A single dose of infliximab administration for a patient with fistulating Crohn's disease led to a fatal course after disseminated tuberculosis and fungal sepsis. Tumor Necrosis Factor–α antagonists are known to have administrative indication in romatoid arthritis, Crohn's disease and psoriasis. However, many important complications may be seen during their usage, especially tuberculosis. In this report, the case was discussed, the literature was reviewed and main points with consensus were presented.

Anahtar Kelimeler

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

Murat Kıyıcı Bu kişi benim

Güze Özal Bu kişi benim

Enver Dolar Bu kişi benim

Macit Gülten Bu kişi benim

Selim Giray Nak Bu kişi benim

Selim Gürel Bu kişi benim

Hüseyin Uslusoy Bu kişi benim

Murat Keskin Bu kişi benim

Yayımlanma Tarihi

1 Haziran 2006

Gönderilme Tarihi

1 Haziran 2006

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2006 Cilt: 32 Sayı: 2

IZ

https://izlik.org/JA44TL22EC

Kaynak Göster

RIS / Bibtex
APA
Kıyıcı, M., Özal, G., Dolar, E., Gülten, M., Nak, S. G., Gürel, S., Uslusoy, H., & Keskin, M. (2006). A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn’s Disease – Is It a Reactivation or IRIS? Journal of Uludağ University Medical Faculty, 32(2), 65-70. https://izlik.org/JA44TL22EC
AMA
1.Kıyıcı M, Özal G, Dolar E, vd. A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn’s Disease – Is It a Reactivation or IRIS? Uludağ Tıp Derg. 2006;32(2):65-70. https://izlik.org/JA44TL22EC
Chicago
Kıyıcı, Murat, Güze Özal, Enver Dolar, vd. 2006. “A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn’s Disease – Is It a Reactivation or IRIS?”. Journal of Uludağ University Medical Faculty 32 (2): 65-70. https://izlik.org/JA44TL22EC.
EndNote
Kıyıcı M, Özal G, Dolar E, Gülten M, Nak SG, Gürel S, Uslusoy H, Keskin M (01 Haziran 2006) A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn’s Disease – Is It a Reactivation or IRIS? Journal of Uludağ University Medical Faculty 32 2 65–70.
IEEE
[1]M. Kıyıcı vd., “A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn’s Disease – Is It a Reactivation or IRIS?”, Uludağ Tıp Derg, c. 32, sy 2, ss. 65–70, Haz. 2006, [çevrimiçi]. Erişim adresi: https://izlik.org/JA44TL22EC
ISNAD
Kıyıcı, Murat - Özal, Güze - Dolar, Enver - Gülten, Macit - Nak, Selim Giray - Gürel, Selim - Uslusoy, Hüseyin - Keskin, Murat. “A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn’s Disease – Is It a Reactivation or IRIS?”. Journal of Uludağ University Medical Faculty 32/2 (01 Haziran 2006): 65-70. https://izlik.org/JA44TL22EC.
JAMA
1.Kıyıcı M, Özal G, Dolar E, Gülten M, Nak SG, Gürel S, Uslusoy H, Keskin M. A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn’s Disease – Is It a Reactivation or IRIS? Uludağ Tıp Derg. 2006;32:65–70.
MLA
Kıyıcı, Murat, vd. “A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn’s Disease – Is It a Reactivation or IRIS?”. Journal of Uludağ University Medical Faculty, c. 32, sy 2, Haziran 2006, ss. 65-70, https://izlik.org/JA44TL22EC.
Vancouver
1.Murat Kıyıcı, Güze Özal, Enver Dolar, Macit Gülten, Selim Giray Nak, Selim Gürel, Hüseyin Uslusoy, Murat Keskin. A Case of Disseminated Tuberculosis After Infliximab Administration for Fistulating Crohn’s Disease – Is It a Reactivation or IRIS? Uludağ Tıp Derg [Internet]. 01 Haziran 2006;32(2):65-70. Erişim adresi: https://izlik.org/JA44TL22EC

ISSN: 1300-414X, e-ISSN: 2645-9027

Uludağ Üniversitesi Tıp Fakültesi Dergisi "Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License" ile lisanslanmaktadır.


Creative Commons License
Journal of Uludag University Medical Faculty is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

2023